PetIQ, Inc. (PETQ) Misses Q4 EPS by 20c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
PetIQ, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results
February 28, 2023 4:05 PM ESTFull Year 2022 Net Sales and Adjusted EBITDA In-Line with Company GuidanceUpdates Adjusted EBITDA MethodologyReports Record Annual Cash from Operations of $48.0 MillionCompletes Complementary, Margin Accretive Acquisition of Rocco & Roxie Provides First Quarter 2023 and Full Year 2023 Outlook
EAGLE, Idaho, Feb. 28, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (PetIQ or the Company) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for the fourth quarter and full year ended December 31, 2022.
Cord Christensen, PetIQs Chairman & CEO, commented, We are pleased to report net... More



